Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Ellis

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
The British Journal of Ophthalmology|June 19, 2004
Effect of mydriasis and different field strategies on digital image screening of diabetic eye diseaseH Murgatroyd, A Ellingford, A Cox, et al.
Environmental Entomology|March 24, 2017
Managed Bumble Bees (Bombus impatiens) (Hymenoptera: Apidae) Caged With Blueberry Bushes at High Density Did Not Increase Fruit Set or Fruit Weight Compared to Open PollinationJ W Campbell, J O'Brien, J H Irvin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 25, 2007
Fear of visual loss in patients with diabetes: results of the prevalence of diabetic eye disease in Tayside, Scotland (P-DETS) studyR Luckie, G Leese, R McAlpine, et al.
Biopharmaceutics & Drug Disposition|November 28, 1997
Effects of pentobarbital on pharmacokinetics and pharmacodynamics of a potent fibrinogen receptor antagonist, L-734,217, in dogsT Prueksaritanont, M T Stranieri, E L Hand, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 2004
Prevalence of diabetic eye disease in Tayside, Scotland (P-DETS) study: methodologyJ D Ellis, G Leese, R McAlpine, et al.
The British Journal of Ophthalmology|October 26, 2000
Glaucoma incidence in an unselected cohort of diabetic patients: is diabetes mellitus a risk factor for glaucoma? DARTS/MEMO collaboration. Diabetes Audit and Research in Tayside Study. Medicines Monitoring UnitJ D Ellis, J M Evans, D A Ruta, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 1, 1995
The development and cross-validation of methods based on radioimmunoassay and LC/MS-MS for the quantification of the class III antiarrhythmic agent, MK-0499, in human plasma and urineJ D Gilbert, T F Greber, J D Ellis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1995
Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and humanT Prueksaritanont, S K Balani, L M Dwyer, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 25, 2005
Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based studyL A Donnelly, A D Morris, B M Frier, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001
PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolitesB K Wong, D DeFeo-Jones, R E Jones, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The British Journal of Ophthalmology|June 19, 2004
Effect of mydriasis and different field strategies on digital image screening of diabetic eye diseaseH Murgatroyd, A Ellingford, A Cox, et al.
Environmental Entomology|March 24, 2017
Managed Bumble Bees (Bombus impatiens) (Hymenoptera: Apidae) Caged With Blueberry Bushes at High Density Did Not Increase Fruit Set or Fruit Weight Compared to Open PollinationJ W Campbell, J O'Brien, J H Irvin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 25, 2007
Fear of visual loss in patients with diabetes: results of the prevalence of diabetic eye disease in Tayside, Scotland (P-DETS) studyR Luckie, G Leese, R McAlpine, et al.
Biopharmaceutics & Drug Disposition|November 28, 1997
Effects of pentobarbital on pharmacokinetics and pharmacodynamics of a potent fibrinogen receptor antagonist, L-734,217, in dogsT Prueksaritanont, M T Stranieri, E L Hand, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 2004
Prevalence of diabetic eye disease in Tayside, Scotland (P-DETS) study: methodologyJ D Ellis, G Leese, R McAlpine, et al.
The British Journal of Ophthalmology|October 26, 2000
Glaucoma incidence in an unselected cohort of diabetic patients: is diabetes mellitus a risk factor for glaucoma? DARTS/MEMO collaboration. Diabetes Audit and Research in Tayside Study. Medicines Monitoring UnitJ D Ellis, J M Evans, D A Ruta, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 1, 1995
The development and cross-validation of methods based on radioimmunoassay and LC/MS-MS for the quantification of the class III antiarrhythmic agent, MK-0499, in human plasma and urineJ D Gilbert, T F Greber, J D Ellis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1995
Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and humanT Prueksaritanont, S K Balani, L M Dwyer, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 25, 2005
Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based studyL A Donnelly, A D Morris, B M Frier, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001
PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolitesB K Wong, D DeFeo-Jones, R E Jones, et al.
Pageof 5